PP2A has been shown to act as a tumor suppressor in some malignancies and its inactivation has been observed in CML MBP cell line (K562) and primary cells [38,39]. This evidence concerns the gene PTPA and chronic myelogenous leukemia, BCR-ABL1 positive.